Artiva Biotherapeutics, Inc.'s total assets for Q3 2025 were $148.86M, a decrease of ― from the previous quarter. ARTV total liabilities were $19.64M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.